跳至主要内容
临床试验/NCT00801320
NCT00801320已完成不适用

Study of Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer (Ovarian Spore)

Beth Israel Deaconess Medical Center8 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
8
主要终点
To collect patient tumor samples that could possibly be used in a subsequent clinical vaccine trial (DF/HCC protocol 07-380).

研究概览

简要总结

The purpose of this research study is to collect tumor samples at the time of surgery and store them for possible use as part of an experimental vaccine study for the participants cancer in the future.

详细描述

  • Even if tumor sample is collected, the participant is under no obligation to participate in the vaccine study.
  • Participants will have their regularly planned surgery as described by their surgeon. During the surgery, tumor samples will be collected. We will only collect tumor that is not needed and could otherwise be thrown away.
  • The tumor samples will be frozen and placed in storage for up to two years.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Clinical suspicion of advanced ovarian, fallopian tube or primary peritoneal cancer as determined by a gynecologic oncologist
  • Patients are planning to undergo primary or secondary debulking surgery as part of standard of care for their disease
  • Estimated life expectancy of 6 months or greater
  • 18 years of age or older

排除标准

  • More than one prior chemotherapy regimen
  • Serious intercurrent illness such as infection requiring IV antibiotics, or significant cardiac disease characterized by significant arrhythmia, unstable ischemic coronary disease or congestive heart failure
  • Known HIV infection
  • Active second malignancy, aside from basal cell or squamous cell carcinoma of the skin
  • Significant autoimmune disease, including psoriasis
  • History of clinically significant venous thromboembolism

结局指标

主要结局

To collect patient tumor samples that could possibly be used in a subsequent clinical vaccine trial (DF/HCC protocol 07-380).

时间窗: 2 years

To gain experience in appropriate clinical processing of tumor samples and determining cell yield.

时间窗: 2 years

次要结局

  • Based on feasibility of collection of blood samples of subjects, quantification of T cell subsets, regulatory T cells, activated memory effector cells, and DC phenotype at pre-surgery and post-surgery time points.(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Avigan, MD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (8)

Loading locations...

相似试验

撤回
不适用
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood SamplesHematologic CancerProstate CancerColorectal CancerLung CancerBreast Cancer
NCT01792882Global BioClinical
进行中(未招募)
不适用
Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or ImmunotherapyCancer
NCT03835520Cliniques universitaires Saint-Luc- Université Catholique de Louvain200
已完成
不适用
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaDesmoid-Type FibromatosisAdult RhabdomyosarcomaChildhood Desmoplastic Small Round Cell TumorMetastatic Childhood Soft Tissue SarcomaChordomaNon-Metastatic Childhood Soft Tissue SarcomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Soft Tissue SarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage II Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7Stage IV Adult Soft Tissue Sarcoma AJCC v7Untreated Childhood RhabdomyosarcomaRhabdomyosarcoma
NCT00919269Children's Oncology Group150
终止
不适用
Sample Collection From Melanoma PatientsMelanoma
NCT00507325M.D. Anderson Cancer Center131
Unknown
不适用
Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseEndometrial NeoplasmsUterine Cervical NeoplasmsOvarian NeoplasmsLeiomyoma
NCT00299481U.S. Army Medical Research and Development Command7,000